Navigation Links
Cynosure Reports Financial Results for the First Quarter of 2011
Date:5/3/2011

#160;In addition, the forward-looking statements included in this press release represent Cynosure's views as of the date of this press release.  Cynosure anticipates that subsequent events and developments will cause its views to change.  However, while Cynosure may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so.  These forward-looking statements should not be relied upon as representing Cynosure's views as of any date subsequent to the date of this press release.

Contact:
Scott Solomon
Vice President
Sharon Merrill Associates, Inc.
Phone: (617) 542-5300
CYNO@investorrelations.comConsolidated Statements of Income (Unaudited)(In thousands, except per share data)Three Months Ended Mar. 31,20112010Revenues$
21,884

$
8,893Cost of revenues 9,803

8,093Gross profit12,081

10,800Operating expensesSelling and marketing

8,756

8,402Research and development  

2,240

1,707General and administrative

2,951

3,233Total operating expenses13,947

13,342Loss from operations(1,866)

(2,542)Interest income, net

54

53Other income (expense), net

214

(151)Loss before income taxes(1,598)

(2,640)Income tax provision

296

172Net loss$
(1,894)

$
(2,812)Diluted net loss per share

$
(0.15)

$
(0.22)Diluted weighted average shares outstanding

12,577

12,711Basic net loss per share

$
(0.15)

$
(0.22)Basic weighted average shares outstanding

12,577

12,711Condensed Consolidated Balance Sheet(In thousands)Mar. 31,Dec. 31,20112010(unaudited)Assets:Cash, cash equivalents and short-term marketable securities

$   81,841$   86,836Accounts receivable, net

10,39710,621Inventories

21,27118
'/>"/>

SOURCE Cynosure, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Cynosure Launches New Workstation and Technology Innovations at American Academy of Dermatology Annual Meeting
2. Cynosure Announces Presentations at Upcoming Investor Conferences
3. Cynosure Reports Second Quarter 2009 Financial Results
4. Cynosure Reports Third Quarter 2009 Financial Results
5. SCOLR Pharma, Inc. Reports Second Quarter 2008 Financial Results
6. AutoImmune Inc. Reports 2008 Second Quarter Financial Results
7. Par Pharmaceutical Reports Second Quarter 2008 Results
8. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
9. Pharmos Corporation Reports 2008 Second Quarter Results
10. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
11. MGT Capital Investments Reports Second Quarter 2008 Financial Results and Provides Update on Recent Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... (PRWEB) July 25, 2014 WABC Radio show ... Pet with Lorry Young will be hosting California-based Vet-Stem, ... about stem cell therapy in pets. Dr. Harman first ... of stem cell therapy for pets suffering from osteoarthritis and ... Regenerative Veterinary Medicine industry forward. , Young has invited Dr. ...
(Date:7/25/2014)...  Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD ) ... and commercialization of a once-daily, oral therapy for the ... financial results for the period ended June 30, 2014. ... Reported cash and cash equivalents totaling $37.4 million on ... 2013.  , Reported a net loss of $3.9 ...
(Date:7/25/2014)... 25, 2014 Sinovac Biotech Ltd. (Nasdaq: ... China , today announced that it will release ... 30, 2014, after market close on Thursday, August 14, 2014 ... the market opening on Friday, August 15, 2014, at 8:00 ... Standard Time) to review the Company,s financial results and provide ...
(Date:7/24/2014)... July 24, 2014 Gain recognition ... Supply Chain of the biotech industry. Nominations are ... Awards, brought to you by the Bio ... of supply chain management professionals for the past ... stakeholders of the Biotech industry – Manufacturers, Service ...
Breaking Biology Technology:Robert J. Harman, DVM, Founder and CEO of Vet-Stem, Inc. to Join New York Radio Host Lorry Young in Upcoming Episode of A “Paws” For Your Pet 2Robert J. Harman, DVM, Founder and CEO of Vet-Stem, Inc. to Join New York Radio Host Lorry Young in Upcoming Episode of A “Paws” For Your Pet 3Galmed Pharmaceuticals Reports First Half 2014 Financial Results 2Galmed Pharmaceuticals Reports First Half 2014 Financial Results 3Galmed Pharmaceuticals Reports First Half 2014 Financial Results 4Galmed Pharmaceuticals Reports First Half 2014 Financial Results 5Galmed Pharmaceuticals Reports First Half 2014 Financial Results 6Sinovac to Host Conference Call to Report Second Quarter 2014 Unaudited Financial Results 2Call for Submission: BSMA’s Supply Chain Management Innovation Awards 2Call for Submission: BSMA’s Supply Chain Management Innovation Awards 3
... , , , LEXINGTON, Mass. ... holding gmbh announced today the launch of the first human cancer ... targeted Next-Generation Sequencing (NGS). The new catalog cancer biochip features 115 ... of cancer by the Wellcome Trust Sanger Institute. , ...
... , , RARITAN, N.J., July 13 ... can accurately predict the prognosis and survival in patients ... published report in the July 10 issue of the ... retrospective study compared how well CTCs and a more ...
... , SAN MARINO, Calif., July 13 ... compounds for HIV/AIDS, autoimmune diseases, and cancer, has retired the majority ... other debt and recently issued new shares. , ... financing through the issuance of shares. This transaction originally was disclosed ...
Cached Biology Technology:First Catalog Cancer Biochip for Sequence Capture Now Available from febit 2Monitoring Circulating Tumor Cells With the CellSearch(R) System Can Predict Prognosis in Metastatic Breast Cancer 2Monitoring Circulating Tumor Cells With the CellSearch(R) System Can Predict Prognosis in Metastatic Breast Cancer 3Monitoring Circulating Tumor Cells With the CellSearch(R) System Can Predict Prognosis in Metastatic Breast Cancer 4Viral Genetics Retires Nearly $3.5 Million Convertible Debt and Provides Updates on Capital Structure and Stock Issuances 2Viral Genetics Retires Nearly $3.5 Million Convertible Debt and Provides Updates on Capital Structure and Stock Issuances 3
(Date:7/25/2014)... molecular testing panel developed at UPMC greatly increases ... for patients with thyroid nodules and cancer, report ... (UPCI), partner with UPMC CancerCenter., The test, available ... diagnostic testing agencies, improved the chances of patients ... according to the study published this month in ...
(Date:7/24/2014)... 2014 -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") announced ... control Phase 3 study of Zerenex (ferric citrate), the ... treatment of hyperphosphatemia in patients with end-stage renal disease ... iRon delivery with FErric CiTrate in EsrD) was published ... Society of Nephrology ( JASN ). ...
(Date:7/24/2014)... disturbance has different effects on different species of ... Universities of Bristol and Exeter which tested fish ... to a flying seagull predator model when exposed ... in European minnows. , Lead author Dr ... said: "Noise levels in many aquatic environments have ...
Breaking Biology News(10 mins):Test increases odds of correct surgery for thyroid cancer patients 2Test increases odds of correct surgery for thyroid cancer patients 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4
... conditions based on results from the previous day,s sample. Scientists ... lab to culture them for analysis a process that ... engineers from the UCLA Henry Samueli School of Engineering and ... concentrations to under one hour, through the development of a ...
... A new University of Illinois study touts the ... for starterssaying that it reduces the inflammation associated with ... fiber changes the personality of immune cellsthey go from ... help us recover faster from infection," said Gregory Freund, ...
... CAMBRIDGE, Mass., March 2, 2010 Fictional candy maker ... chocolate eggs from bad, an eggucator. Likewise, by determining ... discard, scientists are aiming to find their own golden ... Toward that end, Harvard researchers and a team ...
Cached Biology News:UCLA engineers develop faster method to detect bacterial contamination in coastal waters 2UCLA engineers develop faster method to detect bacterial contamination in coastal waters 3An apple a day? Study shows soluble fiber boosts immune system 2An apple a day? Study shows soluble fiber boosts immune system 3Sorting device for analyzing biological reactions puts the power of a lab in a researcher’s pocket 2Sorting device for analyzing biological reactions puts the power of a lab in a researcher’s pocket 3
... number is a new product number, created ... showing no availability yet, please order under ... customer service for assistance. ID ... D H 100 20 mm ...
BD BioCoat Gelatin 100 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of gelatin....
Mouse monoclonal antibody raised against a full length recombinant ATF3. NCBI Entrez Gene ID = ATF3...
... Delivers 4,600 to Over 3 Million Genotypes ... is capable of performing 4,600 to over ... the GenomeLab family of products*, this automated, ... 48 SNPs in each well of an ...
Biology Products: